Switching from Wegovy to Mounjaro: What to Expect

Wegovy and Mounjaro work on appetite-regulating pathways, but they are not identical. Wegovy's active substance, semaglutide, acts on GLP-1 receptors. Mounjaro's active substance, tirzepatide, acts on both GLP-1 and GIP receptors — a dual mechanism that can mean your body responds somewhat differently, even if you have been injecting weekly for some time.

Side effects commonly reported during the transition

Because your prescriber will typically start you at a lower dose of Mounjaro when switching rather than moving straight to an equivalent strength, many people find the transition period manageable. That said, the following are commonly reported when starting or re-titrating on Mounjaro:

• Gastrointestinal effects — nausea, loose stools, constipation, indigestion, and reflux are the most frequently mentioned. These are similar in nature to what many people experienced when starting Wegovy, and often ease within a few weeks as the body adapts.
• Fatigue and headache — some people report feeling more tired or getting headaches in the early weeks, particularly around injection day.
• Changes in appetite and food noise — Mounjaro's dual action means the degree of appetite suppression or "food noise" reduction may feel noticeably different to what you experienced on Wegovy. This is commonly reported in switching reviews and is worth tracking carefully.
• Injection-site reactions — mild redness, itching, or tenderness at the injection site can occur with either medicine; rotating your injection site each week helps reduce this.

Side effects that may ease

Some people who experienced persistent nausea or other gastrointestinal discomfort on Wegovy report that their symptoms shift — sometimes improving, sometimes feeling different — after switching. Individual responses vary considerably, and there is no way to predict in advance how your body will respond.

For a broader overview of what is commonly reported on tirzepatide, see our guide to Mounjaro side effects. If you are curious about the reverse journey, our page on switching from Mounjaro to Wegovy covers that transition too.

According to NHS guidance, both semaglutide and tirzepatide carry a black triangle (▼) status, meaning all suspected side effects should be reported to your healthcare professional and, where applicable, to your national reporting scheme (such as the UK's Yellow Card scheme).

When your medicine changes, the most useful thing you can do is keep a clear record of what you are experiencing and when — so that your prescriber has real data to work with at your next appointment.

GLP Trackr's side-effect tracker is built precisely for this. You can log symptoms day by day — nausea, fatigue, digestive changes, injection-site reactions, mood — and the app builds a timeline that shows patterns over time. That makes it far easier to see whether a symptom is fading, worsening, or linked to a particular day in your injection cycle, rather than relying on memory when you are sitting in front of your prescriber.

Alongside side-effect logging, the daily check-in lets you record energy levels, food noise, sleep, and mood in under a minute each morning — giving you a full picture of how the transition is affecting your day-to-day wellbeing, not just your digestive system. Many people find this especially useful in the weeks after a switch, when it can be hard to tell what is an adjustment response and what might need attention.

You can also explore related topics on managing your journey: understanding whether switching from Wegovy to Mounjaro is right for you, or what people report when switching back to Mounjaro from Wegovy after a period on semaglutide.

Important: if any side effect is severe, persistent, or concerns you at any point during your transition, contact your healthcare professional promptly. GLP Trackr helps you record what you are experiencing so you can have an informed conversation with your prescriber — it is not a substitute for their clinical judgement, and any decisions about your dose or medicine remain theirs to make.

Ready to log your transition properly? GLP Trackr is available free on the App Store and Google Play — start a 7-day free trial and use the side-effect tracker from day one of your switch.